More than 8 million people in the U.S. take blood thinners to prevent dangerous clots. At the same time, the drugs are ...

Bristol-Myers Squibb is upgraded to Buy as its growth portfolio now offsets legacy declines, validating a bullish contrarian ...

The Catholic Church is often associated with vows of poverty and simplicity. But the financial realities of its top leaders ...

BMY Q4 2025 earnings call recap: growth portfolio momentum, pipeline catalysts, 2026 guidance, and Eliquis LOE risks.

Residents, staff, and members of the local community gathered at Elm Bank Care Home in Kettering for a vital Women’s Health ...

Bristol Myers Squibb delivered better than expected fourth quarter earnings, but Eliquis missed expectations while Cobenfy ...

Better adherence to guidelines for food allergen introduction to infants may improve incidence of EoE and food allergy.

Beyond Saudi Arabia, Leonardo DRS continues to pursue partnerships across the Middle East and North Africa, working with government and industry stakeholders in Egypt, Kuwait, Morocco, Bahrain, and ...

Rheumatologists share how they are using AI platforms for clinical documentation, reducing EHR time, streamlining workflows, ...

BostonGene, the developer of the leading AI foundation model for tumor and immune biology, today announced another major independent validation of its AI and machine learning (ML) capabilities in a ...

CCD testers are essential in electronics manufacturing for inspecting components, verifying assemblies, and ensuring product ...

Tempus AI, Inc. (NASDAQ:TEM) is one of the best Nancy Pelosi Stocks to buy in 2026. On January 27, Tempus AI, Inc.